State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, 510060, China.
BMC Ophthalmol. 2020 Dec 11;20(1):487. doi: 10.1186/s12886-020-01760-y.
Choroidal ganglioneuroma is an extremely rare tumor, and there is little knowledge regarding its pathogenesis. We aimed to investigate the phenotypic and genetic alterations in one sporadic patient with a rare case of bilateral choroidal ganglioneuroma.
A 6-year-old boy with histological diagnosis of bilateral ganglioneuroma was recruited for the study. Comprehensive ophthalmic examinations were performed. Genomic DNA was extracted from the peripheral blood samples collected from the patient, his unaffected family members, and 200 unrelated control subjects from the same population. Whole exome sequencing was performed and raw reads were aligned to the human genome reference (hg19) using Burrows-Wheeler Aligner. DNA from all available family members was Sanger sequenced for segregation analysis.
Extensive bilateral retinal detachments were observed via optical coherence tomography. Diffuse thickening of choroid was identified with ultrasound B scan and magnetic resonance imaging. Genetic analysis revealed the presence of a novel heterozygous PTEN frameshift mutation, c.498delA (p.Thr167LeufsTer16), in exon 6. It was present in the affected individual, but not in any of the family members. Genetic analysis revealed that there was no mutation in neurofibromatosis-related genes in the family. Upon performing comprehensive systemic examinations, no obvious abnormalities in other organs were observed.
A novel de novo PTEN mutation was identified in a patient with bilateral choroidal ganglioneuroma. Although PTEN mutations are known to induce multiple abnormalities, choroidal ganglioneuroma can be the first manifestation without abnormalities in other organs. Further studies are needed to confirm the association between choroidal ganglioneuroma and PTEN mutation.
脉络膜神经节细胞瘤是一种极其罕见的肿瘤,其发病机制知之甚少。我们旨在研究一例罕见双侧脉络膜神经节细胞瘤患者的表型和遗传改变。
招募一名 6 岁男孩进行研究,该男孩经组织学诊断为双侧神经节细胞瘤。进行全面眼科检查。从患者、未受影响的家庭成员和来自同一人群的 200 名无关对照中采集外周血样本,提取基因组 DNA。对全外显子组进行测序,使用 Burrows-Wheeler Aligner 将原始读数与人类基因组参考(hg19)对齐。对所有可用的家庭成员的 DNA 进行 Sanger 测序以进行分离分析。
光学相干断层扫描显示广泛的双侧视网膜脱离。超声 B 扫描和磁共振成像显示脉络膜弥漫性增厚。遗传分析显示存在一种新的杂合性 PTEN 移码突变,c.498delA(p.Thr167LeufsTer16),位于外显子 6 中。该突变存在于受影响的个体中,但不存在于任何家庭成员中。遗传分析显示家族中无神经纤维瘤相关基因突变。进行全面系统检查后,未发现其他器官明显异常。
在一名双侧脉络膜神经节细胞瘤患者中发现了一种新的从头 PTEN 突变。虽然已知 PTEN 突变会引起多种异常,但脉络膜神经节细胞瘤可能是没有其他器官异常的首发表现。需要进一步研究来确认脉络膜神经节细胞瘤与 PTEN 突变之间的关联。